Pier Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-61,065
| Closed | -$10.8M | – | 130 |
|
2021
Q3 | $10.8M | Sell |
61,065
-2,186
| -3% | -$387K | 1.12% | 44 |
|
2021
Q2 | $10.2M | Buy |
63,251
+19,033
| +43% | +$3.07M | 1.02% | 60 |
|
2021
Q1 | $7.58M | Buy |
44,218
+17,128
| +63% | +$2.93M | 0.72% | 79 |
|
2020
Q4 | $5.95M | Buy |
27,090
+845
| +3% | +$186K | 0.63% | 87 |
|
2020
Q3 | $4.36M | Sell |
26,245
-43,521
| -62% | -$7.23M | 0.64% | 88 |
|
2020
Q2 | $7.97M | Buy |
69,766
+7,494
| +12% | +$856K | 1.27% | 19 |
|
2020
Q1 | $4.79M | Buy |
+62,272
| New | +$4.79M | 1.06% | 48 |
|